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Abstract
Background: Toll-like receptors (TLRs) play a central role in innate immunity. TLRs are membrane
glycoproteins and contain leucine rich repeat (LRR) motif in the ectodomain. TLRs recognize and respond
to molecules such as lipopolysaccharide, peptidoglycan, flagellin, and RNA from bacteria or viruses. The
LRR domains in TLRs have been inferred to be responsible for molecular recognition. All LRRs include the
highly conserved segment, LxxLxLxxNxL, in which "L" is Leu, Ile, Val, or Phe and "N" is Asn, Thr, Ser, or
Cys and "x" is any amino acid. There are seven classes of LRRs including "typical" ("T") and "bacterial" ("S").
All known domain structures adopt an arc or horseshoe shape. Vertebrate TLRs form six major families.
The repeat numbers of LRRs and their "phasing" in TLRs differ with isoforms and species; they are aligned
differently in various databases. We identified and aligned LRRs in TLRs by a new method described here.
Results: The new method utilizes known LRR structures to recognize and align new LRR motifs in TLRs
and incorporates multiple sequence alignments and secondary structure predictions. TLRs from thirty-
four vertebrate were analyzed. The repeat numbers of the LRRs ranges from 16 to 28. The LRRs found in
TLRs frequently consists of LxxLxLxxNxLxxLxxxxF/LxxLxx ("T") and sometimes short motifs including
LxxLxLxxNxLxxLPx(x)LPxx ("S"). The TLR7 family (TLR7, TLR8, and TLR9) contain 27 LRRs. The LRRs
at the N-terminal part have a super-motif of STT with about 80 residues. The super-repeat is represented
by STTSTTSTT or _TTSTTSTT. The LRRs in TLRs form one or two horseshoe domains and are mostly
flanked by two cysteine clusters including two or four cysteine residue.
Conclusion: Each of the six major TLR families is characterized by their constituent LRR motifs, their
repeat numbers, and their patterns of cysteine clusters. The central parts of the TLR1 and TLR7 families
and of TLR4 have more irregular or longer LRR motifs. These central parts are inferred to play a key role
in the structure and/or function of their TLRs. Furthermore, the super-repeat in the TLR7 family suggests
strongly that "bacterial" and "typical" LRRs evolved from a common precursor.
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Background
Toll-like receptors (TLRs) play a central role in innate
immunity [1-3]. TLRs are type I integral membrane glyco-
proteins consisting of leucine rich repeat (LRR) motif in
the ectodomain (ECD), and cytoplamic signaling
domains known as Toll IL-receptor (TIR) domains, joined
by a single trans membrane helix (Figure 1). They recog-
nize and respond to a variety of components derived from
pathogenic or commensal microorganisms principally
bacteria and viruses. These molecules include lipids such
as lipopolysaccharide (LPS) from Gram-negative bacteria
and peptidoglycan fragments from bacterial cell walls,
proteins such as flagellin and nucleic acids such as single-
stranded and double-stranded RNA and unmethylated
CpG DNA from bacteria or viruses. The ECDs including
LRRs have been inferred to recognize directly various lig-
ands. The TLR family counts 10 members in human and
12 in mice and Takifugu rubripes. Six major families of
vertebrate TLRs have been proposed in a molecular den-
drogram [4].
Leucine-rich repeat (LRR)-containing domains are present
in over 6000 proteins listed in PFAM, PRINTS, SMART,
and InterPro data bases [5-8]. All LRR repeats can be
divided into a highly conserved segment (HCS) and a var-
iable segment (VS). The HCS part consists of an eleven res-
idue stretch, LxxLxLxxNxL, or a tweleve residue stretch,
LxxLxLxxCxxL, in which "L" is Leu, Ile, Val, or Phe, "N" is
Asn, Thr, Ser, or Cys, and "C" is Cys, Ser or Asn [7,9].
Seven classes of LRRs have been proposed, characterized
by different lengths and consensus sequences of the VS
part of repeats [9,10]. They are "RI-like", "CC", "bacte-
rial", "SDS22-like", "plant specific", "typical", and
"TpLRR". Each subfamily of small leucine-rich repeat pro-
teoglycan (SLRP) has LRRs from more than one of the
seven classes [8,11]. The structures of twenty-two different
proteins that contain LRRs are available [12-51]. They
include TLR3 and CD14 [48-50]. The LRR domains in all
known structures adopt an arc shape. Most of the known
LRR structures have a cap, which shields the hydrophobic
core of the first LRR at the N-terminus or the last LRR at
the C-terminus. In extracellular proteins or extracellular
domains, these caps frequently consist of cysteine clusters
including two or four cysteine residues [8,9].
The indicated repeat number of LRRs and its "phasing"
(that is, what segment or residue corresponds to the
beginning of a repeating unit) in individual TLRs are dif-
ferent among the databases (or researchers) and species.
This difference reflects the irregularity of LRR motifs in
TLRs. Over one hundred complete TLRs are available. Sev-
eral methods of protein secondary structure predictions
such as Proteus and SSPro4.0 show a correspondence of
about 75% [52-54]. For the identification of LRRs we pro-
pose a new method, which uses the known structures of
several LRRs, multiple sequence alignments and second-
ary structure predictions of TLRs. This new method indi-
cates that each of the six recognized TLR families can be
characterized by its LRR motifs, their repeat number and
the motifs of two cysteine clusters flanking the LRRs. The
actual repeat number of LRRs is generally larger than
those reported in the databases. The present analysis leads
to the hypothesis that all the LRRs in TLRs form one or
two horseshoe domains.
Results
A new method for the identification of LRRs within TLRs
LRR known structures
All of the LRR domains in one protein form a single con-
tinuous structure and adopt an arc or horseshoe shape.
On the inner, concave face there is a stack of parallel β-
strands and on the outer, convex face there are a variety of
secondary structures such as α-helix, 310-helix, polypro-
line II helix, or a tandem arrangement of β-turns [8,55].
The HCS part of all the LRRs consists of LxxLxLxxNxL or
LxxLxLxxCxxL,, as noted, in which "L" is Leu, Ile, Val, or
Phe, "N" is Asn, Thr, Ser, or Cys, and "C" is Cys, Ser or Asn
[7,9]. The short β-strands are mostly formed by three res-
idues at positions 3 through 5 in the HCS part. In most
LRR proteins the β-strands on the concave face and
(mostly) helical elements on the convex face are con-
nected by short loops or β-turns. Four leucine residues at
positions 1, 4, 6 and 11 participate in the hydrophobic
core in LRR arcs. Similarly, conserved hydrophobic resi-
dues in the VS parts of the seven LRR classes participate in
the hydrophobic core. The side chains of asparagine at
position 9 form hydrogen bonds in the loop structure [6].
Structural alignments of the known LRR structures reveal
that the LRR motif is surprisingly variable (Table 1). The
lengths of LRRs range from 20 to 43 residues. Leucines at
positions 1, 4, 6 and 11 of the HCS part are sometimes
replaced by Met, Ala, or Cys, as seen in TLR3 [49,50],
Internalin A (Inl-A) [26], and Internalin B (Inl-B) [22-24].
Leucines at positions 1 and 11 are also occupied by rela-
tively hydrophilic residues such as Gly, Thr, Asn and Tyr.
Structural organization of vertebrate TLRs Figure 1
Structural organization of vertebrate TLRs. Mangenta is signal 
peptide sequence. Green is LRRNT (the cysteine clusters on 
the N-terminal side of LRRs) and LRRCT (the cysteine clus-
ters on the C-terminal side of LRRs). Yellow is LRR domain. 
Blue is transmembrane region. Light blue is TIR domain.
 
ECD domain Cytoplasmic region
LRR domain TIR domain 
 LRRNT                                        LRRCT ↑
Signal peptide Transmenbrane region
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Furthermore, asparagine at position 9 is occupied by
hydrophobic residues such as Val, Leu and Ile. It is clear
that many LRRs do not keep the complete HCS pattern
and are irregular. Eighteen of the 22 known structures
contain irregular LRRs. Most of the irregular HCSs can be
classified into four groups; LxxLxLxx(L/I/M)xL, LxxLx-
Lxx(R/K/E)xL, LxxLxLxx(N/S/T/A)xx, and LxxLxLxxxxx in
which residues in boldface are irregular. Also there are rare
examples,  xVxxLxLxxNxL and PxxLxLxxNxL in follicle-
stimulating hormone receptor (FSHr), and LxxLxGxxS/PxI
in Inl-C and DLC1 (Table 1). Furthermore, an irregular
LRR with (L/x)xx(L/A)xCxx(L/R)xLxxVPxxIPxx, which
belongs to the "bacterial" motif, is frequently observed at
the first LRR (LRR1) at the N-terminus of the LRR domain
(Table 1).
Multiple sequence alignment
Mammalian TLR2 contains 20 LRRs, as described later.
The PFAM program detects only 5–7 of the 20 LRRs, while
the InterPro database (20 August, 2006) counts 13 in
chicken, 14 in human, Cynomolgus monkey, dog and
Chinese hamster, and 18 in bovine (Table 2). Figures 2
and 3 show the multiple sequence alignment of the LRR
domain in mammalian TLR2 from 14 species. The sixth
LRR (LRR6) shows canonical and irregular LRRs whose
HCS parts consist of LxxLxIxx(S/T/N)xL and LxxLxIxx(Q/
D)xL or LxxLxIxxLxL, respectively. The VS part is "typical".
Both canonical and irregular LRR are also seen in LRR9
and LRR10. Furthermore, the HCS part of LRR4 shows
LxxLxLxxNxY in which position 11 is tyrosine. This pat-
tern was recognized in the known structures of TLR3 and
lingo-1 (Table 1). The pairwise sequence identities are
>35%. Thus, all LRRs in TLR2s from the 14 species can be
reasonably regarded as an LRR motif.
Protein secondary structure prediction
The result of the protein secondary structure prediction of
human TLR2 having 20 LRRs is shown in Figure 4. Both
SSpro4.0 and Proteus predict that 15 of the 20 LRRs prefer
β-strands at positions 3 through 5 and/or its neighboring
positions in the HCS part. They include all five irregular
motifs, LRR4, LRR5, LRR7, LRR9, and LRR11. The occur-
rence of β-strands in LRR6 is predicted only by Proteus.
However, LRR6 with the HCS part of LEELEIDASDL is
clearly a canonical LRR. All twenty including LRR6 can be
reasonably identified as LRR motifs.
The identification of LRRs within TLRs
These analyses of the known LRR structures, the multiple
sequence alignments and the secondary structure predic-
tions of TLR2 provide strong evidence that allow us to
identify LRRs over an extended range of sequences and
inferred structures. Taken together four steps for the iden-
tification of LRRs in each member of TLRs were used.
Step 1. Detection of LRRs by the PFAM program
Step 2. Identification of a candidate LRR that can not be
recognized by PFAM.
Step 3: Evaluation of protein secondary structure predic-
tions by Proteus and SSpro4.0.
Step 4. Determination of all LRRs in each member based
on the results obtained by Steps 1–3.
In Step 2, the LRR candidates are selected using the crite-
rion that they are longer than 18 residues and that the
HCS part consisting of LxxLxLxxNxL occupies at least
hydrophobic residues at positions 4 and 6. The candidate
includes irregular motifs that are similar to LRRs recog-
nized by the known structures. In case there are TLRs from
many species, multiple sequence alignments are also con-
sidered for identification. In Step 3, the preference of β-
strand in the HCS part of the LRR candidate selected by
Step 1 and Step 2 was investigated. In Step 4, when the can-
didate prefers β-strand by either Proteus or SSpro4.0 (at
least in one species), it is identified as an LRR. In some
cases such as LRR12 in TLR14, the initial LRR candidate
was changed into another LRR based on the results of the
secondary structure prediction. The crystal structure of
human TLR3 [52,53] contains 25 LRRs. The present
method confirmed this. In contrast, the PFAM and SMART
programs predicted only 16–17 LRRs and the databases
have reported 22 LRRs (Table 2).
There are two exceptions. In five mammalian TLR6s with
20 LRRs, LRR9, PTLLN(F/V/L)TL(N/Q)H(I/V), that con-
tains Pro at position 1 is not predicted to have a β-strand
by both prediction methods (Figure 4). However, this pat-
tern is seen in FSHr (Table 1). Similarly, in human and pig
TLR10 with 20 LRRs LRR10, GGK(A/V)YLDHNSF, is not
predicted to have a β-strand by both programs (Figure 4).
However, this pattern shows remarkable similarity with




The repeat number and "phasing" of LRRs in TLRs are
summarized in Table 2 and Figures 5, 6, 7, 8, 9, and 10.
The number of LRRs identified within TLRs range from 16
to 28; these numbers are larger than those reported in
most databases. The "typical"; "T", LRR, LxxLxLxxNxLxx-
LxxxxFxxLxx, occurs most frequently followed by shorter
motifs including LxxLxLxxNxLxxLPx(x)LPxx ("bacterial";
"S") with 19–21 residues. Moreover, all of the C-terminal
LRR consists of LxxLxLxxNP(F/L)xCxCxxxx(F/L)xxxx. The
TLRs contain a variety of irregular LRRs (Figures 5, 6, 7, 8,
9, and 10). The first LRR at the N-terminus (LRR1) is fre-BMC Genomics 2007, 8:124 http://www.biomedcentral.com/1471-2164/8/124
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Table 1: Irregular LRR motifs observed in the known structures of LRR-containing proteins
Proteina Nb Irregular LRRs PDB
Position  Amino acid sequencec
LxxLxLxxNxL
TLR3 25 LRR1 HEVADCSHLKL TQVPDDLPTN 1ZIW











Slit 6 LRR1 GTTVDCTGRGL KEIPRDIPLH 1W8A
Lingo-1 14 LRR8 LIVLRLRHLNI NAIRDYSFKRLYR 2ID5
LRR9 LKVLEISHWPY LDTMTPNCLYGLN
Decorin 12 LRR1 LRVVQCSDLGL EKVPKDLPPD 1XCD
Biglycan 12 LRR1 LRVVQCSDLGL KAVPKEISPD 2FT3
FSHr 10 LRR6 LQKVLLDIQDN INIHTIERNSFVGLSFE 1XWD
LRR7 SVILWLNKNGI QEIHNCAFNGTQ
LRR9 PVILDISRTRI HSLPSYGLEN
Inl-A 16 LRR1 VTTLQADRLGI KSIDGLEYLNN 1O6V
Inl-C 7 LRR1 VQNFNGDNSNI QSLAGMQFFTN 1XEU
LRR7 VNWIDLTGQKC VNEPVKYQPEL
U2snRNPA' 5 LRR1 DRELDLRGYKI PVIRNLGATLDQ 1A9N
RabGGTα 5 LRR1 VRVLHLAHKDL TVLCHLEQLLL 1DCE
DLC1 6 LRR1 KVELHGMIPPI EKMDATLSTLKA 1DS9
TAP 4 LRR1 QQALDLKGLRS DPDLVAQNIDVVLNRRSCMAATLRII 1FT8
EENIPE
PGIP 10 LRR1 VNNLDLSGLNL PKPYPIPSSLANLPYL 1OGQ
YoPM 16 LRR1 AHELELNNLGL SSLPELPPH 1G9U
LRR16 VEDLRMNSERV DPYEFAHETTDKLEDDVFE
hRI 16 LRR15 LEQLVLYDIYW SEEMEDRLQALEKDKP 1Z7X
pRI 17 LRR1 W_NLDIHCEQL SDARWTELPLQQ 2BNH
RanGAP 10 LRR2 LEIAEFSDIFT GRVKDEIPEALRLLLQALLKCPK 1YRG




ceTmod 5 LRR1 LKEVNINNMKR VSKERIRSLIEAACNSKH 1PGV
LRR4 IVEFKADNQRQ SVLGNQVEMDMMMAIEENES
LRR5 LLRVGISFASM EARHRVSEALERNYERVRL
Skp2 11 LRR1 WQTLDLTGKNL HPDVTGRLLSQG 1FQV
LRR4 LQNLSLWFLRL SDPIVNTLAKNSN /2ASS
LRR7 ITQLNLSGYRK NLQKSDLSTLVRRCPN
LRR10 LKTLQVFGIVP DGTLQLLKEA
aFSHr, follicle-stimulating hormone receptor; Inl-A, internalin A; Inl -C, internalin C; U2snRNPA', spliceosomal U2A' protein; RabGGTα, rab 
geranylgeranyltransferase α-subunit; DLC-1, Chlamydomonas outer arm dynein light chain 1; TAP, mRNA export factor; PGIP, polygalacturonase-
inhibiting protein; RI, ribonuclease inhibitor, RanGAP, GTPase-activating protein; Tmod, tropomodulin; Skp2, S-phase kinase-associated protein 2; h, 
human, p, pig; ce, Caenorhabditis elegans: b N; the repeat number of LRRs identified in individual known LRR structures.c HCS, highly conserved 
segment of LRR; VS, variable segment of LRR. Residues in boldface cause irregular motif.BMC Genomics 2007, 8:124 http://www.biomedcentral.com/1471-2164/8/124
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Table 2: The repeat number of LRRs and its flanking cysteine clusters in vertebrate TLRs
Famliya Protein Speciesb NL
c LRRNTd LRRCTd NB
e
TLR1 TLR1 h, m, p 20(8–9) No CxCx25Cx20C 1
"t 2 1 CxCx29Cx20CC x C x 29Cx20C 1
TLR2 h, m, p, b, r, d, ra, g, ho, dwb, ha, cm, n 20(14–18) Cx5CC x C x 24Cx20C 1
TLR2.1 c 20(13) Cx2Cx5CxC CxCx24Cx20C 1
TLR2.2 c 20(13) Cx2Cx5CxC CxCx24Cx20C 1
TLR2 t 20 Cx2Cx5CxC CxCx25Cx20C 1
TLR2 jf 19 Cx2Cx5CxC CxCx25Cx20C 1
TLR2 z 21 Cx3CxCx5CxC CxCx24Cx20C 1
TLR6 h, m, r, p, b 20(13–14) No CxCx25Cx20C 1
TLR10 h, p 20(12) No CxCx25Cx20C 1
TLR14 t, z 21 Cx10CC x C x 25Cx20C 1
TLR3 TLR3 h, m, b, r, bu, rm, z 25(22–24) Cx8CC x C x 25Cx18C 1
"t 2 5 Cx8CC x C x 26Cx18C 1
"j f 2 7 Cx8CC x C x 24Cx18C 1
TLR as 27 Cx15CC x C x 24Cx18C 1
"r t 2 7 Cx15CC x C x 24Cx18C 1
"g o 2 7 Cx14CC x C x 24Cx18C 1
TLRII rt 27 Cx6Cx17CC x C x 24Cx18C 1
TLR4 TLR4 h, lg, pc, ob, or 23(21) Cx10CC x C x 23Cx17C 1
" m, p, r, ch, ho, b, ab, n, 23(18–19) Cx10CC x C x 23Cx18C 1
" ha, ra 23 Cx10CC x C x 23Cx15C 1
TLR4b z 23 Cx10CC x C x 23Cx18C 1
TLR4 h [Q5VZ17] 16 Cx10CC x C x 23Cx18C 1
"d 1 6 N o CxCx23C 1
TLR5 TLR5 h, m, r, p, b, jhm 22(15–16) Cx11CC x C x 24Cx18C 1
"t 2 2 Cx10CC x C x 24Cx22C 1
"r t 2 2 Cx8CC x 27C 1
TLRS5 t 23 Cx8CC x 26C 1
TLR11 TLR11 M 25(11) Cx17Cx11Cx20CC x C x 24Cx19C 1
TLR12 m 24(17) Cx17Cx11Cx20CC x C x 24Cx19C 1
TLR13 m 27(21) Cx11CC x C x 24Cx16C 1
TLR21 t 27 Cx10CC x C x 24Cx15C 1
TLR22 t 27 Cx8CC x C x 24Cx18C 1
TLR23 t 27 Cx14CC x C x 24Cx18C 1
TLR7 TLR7 H, m, d 27(27–28) Cx14CC x C x 24Cx18C 2
"t 2 7 Cx12CC x C x 24Cx18C 2
TLR8 h, m, p 27(24–26) Cx12CC x C x 24Cx18C 2
"t 2 7 Cx13CC x C x 24Cx18C 2
TLR9 h, m, p, b, d, ca, ho, s, mnm 27(26) Cx9CC x C x 23Cx18C 2
" t, jf, gsb 27 Cx10CC x C x 23Cx18C 2
TLR gp 28, 26 ? CxCx24Cx18C 2
Others TLRa Jl 21 Cx8CC x C x 22C12C 1
TLRb jl 21 Cx8CC x C x 22Cx20C 1
TLR15 c 21 No CxCx24Cx20C 2
aThe six families and others. bAbbreviations: ab, American bison; as, Atlantic salmon; b, bovine; c, chicken; ca, cat; ch, Chinese hamster; cm, 
Cynomolgus monkey; d, dog; dwd, Domestic water buffalo; g, goat; go, Goldfish; gp, green puffer; gsb, Gilthead sea bream; h, human; ha, hamster; 
ho, horse; jf, Japanese flounder; jhm, Japanese house mouse; jl, Japanese lamprey; lg, lowland gorilla; m, mouse; mnm, Ma's night monkey; n, Nilgai; 
ob, Olive baboon; or, Orangutan; p, pig; pc, Pygmy chimpanzee; r, rat; ra, rabbit; rm, Rhesus macaque; rt, Rainbow trout; s, sheep; t, Takifugu 
rubripes; z, Zebrafish. cNL; the repeat number of LRRs. The number of parenthesis is NL reported in the Interpro datbase.d LRRNT, the cysteine 
clusters on the N-terminal side of LRRs; LRRCT, the cysteine clusters on the C-terminal side of LRRs. eNB; the number of horseshoe domains of 
the LRRs.BMC Genomics 2007, 8:124 http://www.biomedcentral.com/1471-2164/8/124
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quently irregular, e.g. (L/x)xx(L/A)xCxx(L/R)xLxxVPxx-
IPxx. This motif has been seen in the structures of TLR3,
Slit, decorin, and biglycan, as noted. (Table 1). Methio-
nine and tryptophan sometimes occupy positions 1, 4, 6
and 11 in the LxxLxLxxNxL motif, which are strongly
hydrophobic. Moreover, as recognized in the known LRR
structures, there are rare examples, xVxxLxLxxNxL, PxxLx-
LxxNxL and LxxLxGxxS/PxI. The first motif is sometimes
observed in LRR7 in human TLR10, LRR8 in Takifugu
rubripes TLR14, LRR4 in chicken TLR15, LRR8 in human
TLR4, and LRR16 in human TLR9 (Figure 5, 6, 7, 8, 9, and
10). Furthermore, the HCS parts of a twelve residue
stretch, LxxLx(L/V/M/F)xx(S/N)xx(F/M), are sometimes
observed; they include LRR5 in TLR2 from pig, bovine,
nilgai, and domestic water buffalo with 20 LRRs (Figures
2 and 3), LRR11 in mouse TLR4 with 23 LRRs, and LRR14
in TLR4 from pig, bovine, rabbit, and nilgai with 23 LRRs.
LRRs in the six major families of TLRs
There are six major families of vertebarate TLRs [4]. The
TLR1 family consists of TLR1, TLR2, TLR6 and TLR10. This
family contains 19–21 LRRs and has fewer numbers than
do the other families except for Dog TLR4 [Q8SQH3] [56]
and human TLR4 variant [Q5VZ17] in the TLR4 family.
Mammalian TLR1 contains 20 LRRs (Table 2). In contrast,
Takifugu rubripes TLR1 [4] has one additional LRR at the
N-terminus whose sequence is RNYIDLSS-
RNLSSVPGDLPKE, that is a "bacterial" type. Mammalian
and Takifugu rubripes TLR2 contains 20 LRRs. Japanese
flounder TLR2 lacks one LRR that corresponds to LRR7 in
The multiple sequence alignment of LRRs within mammalian TLR2 from 14 species Figure 2
The multiple sequence alignment of LRRs within mammalian TLR2 from 14 species. bTLR2   [Q95LA9], nTLR2 [Q2V897], 
dwbTLR2 [Q2PZH4], gTLR2 [ABI31733], pTLR2 [Q59HI8], hoTLR2   [AAR08196], hTLR2 [O60603], cmTLR [Q95M53], 
dTLR2 [Q689D1], raTLR2 [AAM50059], mTLR2 [Q9QUN7],   rTLR2 [Q6YGU2], chTLR2 [Q9R1F8], cTLR2.1 [Q9DD78], 
cTLR2.2 [Q9DGB6].  Abbreviations: b, Bovine;   n, nilgai; dwb, domestic water buffalo; g, goat;  p, pig; ho, horse; h, human; cm, 
Cynomolgus   monkey; d, dog ; ra, rabbit; m, mouse; r, rat; ch,  Chinese hamster; c, chicken.   This panel   shows the sequences 
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the 20 LRRs [57]. Conversely, zebrafish TLR2 has one
additional LRR at the N-terminus, as does Takifugu
rubripes TLR1. This TLR1 family shows a feature that irreg-
ular LRRs mainly concentrate at the central part of the LRR
domain. In the TLR3  family, mammalian, Takifugu
rubripes and Zebrafish TLR3 contain 25 LRRs as was con-
firmed by the crystal structure of human TLR3 [52,53].
However, Japanese flounder TLR3 [57] contains two addi-
tional LRRs. Similarity sequence search indicates that TLRs
from rainbow trout, Atlantic salmon, and goldfish are
very similar to Japanese flounder TLR3. TLR4 that consti-
tute the TLR4 family contains 23 LRRs. Fourteen of the 23
LRRs are similar to "typical". Seven LRRs are irregular. As
seen in the TLR1 family, 5 of the 7 irregular LRRs are in the
central part of the LRR domain. Dog TLR4 [Q8SQH3] [56]
and human TLR4 variant [Q5VZ17] are shorter by about
200 amino acids at the N-terminus. These two TLRs con-
tain only 16 LRRs. It is also predicted that dog TLR4 has
no transmembrane region (Figure 7). TLR5 contains 22
LRRs. Ten of these 22 LRRs are clearly "typical". LRR15 in
mammalian TLR5 is only 19 residues (Figure 7); the
homolog in Takifugu rubripes and rainbow trout is 24 res-
idues long. The TLR11 family contains 24–27 LRRs. Most
of LRRs in mouse TLR11, TLR12, and TLR13 are "typical".
The same feature is observed in Takifugu rubripes TLR21,
TLR22 and TLR23. Two Japanese lamprey TLRs appear to
belong to the TLR1 family.
The TLR7 family consists of TLR7, TLR8 and TLR9 and
contains 27 LRRs. Cross dot plots were computed for all
of TLR7, TLR8, and TLR9 from human and mouse, and
green puffer TLR. More important the super-motif is about
80 residues. Superposition of 21 ((7 × 6)/2) cross dot-
plots for the seven proteins emphasize the super-repeat of
LRRs at the N-terminal part of the LRR domain (Figure 11)
[11]. This super-motif comes from nine LRRs from LRR1
to LRR9 in TLR7 and TLR8, and from eight LRRs from
LRR2 to LRR9 in TLR9 (Figure 12). The sequence align-
The multiple sequence alignment of LRRs within mammalian TLR2 from 14 species Figure 3
The multiple sequence alignment of LRRs within mammalian TLR2 from 14 species. This panel continued from Figure 2 shows 
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ment reveals two types of LRR, S and T. The type S LRR is
observed in the first, fourth, and seventh of the 9 tandem
LRRs. All other LRRs are type T. Although the third, the
sixth and the seventh LRRs is longer than the second, the
fifth and the eighth LRRs, their C-terminal VS parts keep
the pattern of LxxxxFxxLxx that is seen in "typical" motif.
Consequently their LRRs are type T. Thus, there are three
super-repeats, STTSTTSTT, in TLR7 and TLR8, and two
and two-third super-repeats, _TTSTTSTT, in TLR9. Green
puffer TLR forms two horseshoe domains of LRRs. The
first domain is homologous to the TLR7 family and thus
contains also the super-repeat of STTSTTSTT (Figure 12).
LRR15 located at the central part of the 27 LRRs consists
of long amino acid sequence with 73 residues in TLR7, 64
in TLR8, and 58 in TLR9, as seen in TLR15. This long LRR
motif is observed in chicken TLR15. In all the case the next
LRR, LRR16, is an irregular LRR that is described by (G/
N)xLxLxxNx(I/L)xxVxxxxFxxLxx is similar to "typical"
motif, although position 1 in the HCS part is not occupied
by leucine.
Two cysteine clusters flanking the LRR domain
The LRRs within most of TLRs are flanked by two cysteine
clusters, each of which contains two to five cysteine resi-
dues (Table 2 and Figures 5, 6, 7, 8, 9, and 10). Here the
cysteine clusters on the N- and C-terminal sides of LRRs
are termed LRRNT and LRRCT, respectively [58]. The N-
terminal cluster usually consists of two cysteines, Cx5–14C,
but sometimes 3, 4 or 5 cysteines. With high frequency, as
noted, the last cysteine of the clusters occupies a structur-
ally equivalent position to those of leucines in the HCS
part of LRR1. The Cx8C motif in TLR3 and the Cx10C motif
of TLR4 form a disulfide bond [52,59], as does the Cx12C
motif in GPIbα [41]. The Cx5–14C motifs presumably form
disulfide bonds. The C-terminal clusters, excepting those
in three TLRs (Table 2), contain four cysteines consisting
of CxCx22–25Cx15–20C. The spacing between the first and
the second cysteine that are contained in the last LRR is
the same for all the families. The other spacing appears to
characterize each family. The CxCx25Cx18C motif in TLR3
forms two disulfide bonds between the first and the third
cysteines, and between the second and the fourth
cysteines [52]. Such pairs of disulfide bonds have been
observed for the CxCx20Cx21C  motif in Nogo receptor
[38,39] and the CxCx20Cx19C  motif in Slit [49]. The
disulfide bond connectivity can be inferred for TLRs. The
C-terminal cluster for primate TLR4 (CxCx23Cx17C) is dif-
ferent from that of other mammalian TLR4
(CxCx23Cx18C). Only in rainbow trout TLR5 and Takifugu
rubripes TLRS5 having no TIR domain, does the C-termi-
nal cluster consists of two cysteines. There are no N-termi-
nal cysteine clusters in TLR1, TLR6, TLR10, TLR15, and
dog TLR4. However, the N-terminal amino acid sequence
flanking the LRR domain might form a capping structure.
Discussion
LRRs within human TLRs
The present analyses of LRRs within vertebrate TLRs indi-
cate that there are at least two types of LRR motifs; "typi-
cal"; "T", LRR, LxxLxLxxNxLxxLxxxxFxxLxx and
"bacterial"; "S", LRR, LxxLxLxxNxLxxLPx(x)LPxx. Verte-
brate TLRs contain 16–28 LRRs (Table 2 and Figures 5, 6,
7, 8, 9, and 10). Bell et al., [60] have proposed that the
ECDs of human TLRs comprised 19–25 LRRs including
both "T" and "S" LRRs. Each member of human TLRs con-
tain 1–2 times less LRRs than those identified here. Fur-
thermore, in the TLR1  family (TLR1, TLR2, TLR6 and
TLR10) the LRRs at the central parts are aligned differently
to each other. Such a difference is also seen in TLR4, TLR5,
and TLR7. The alignments of TLR3, TLR8 and TLR9 are
nearly identical except the first LRR at the N-terminus of
the LRR domain and the last LRR at its C-terminus.
The secondary structure prediction of human TLR2 by  SSpro4.0 and Proteus Figure 4
The secondary structure prediction of human TLR2 by 
SSpro4.0 and Proteus. The signal peptide and extracellular 
domain of hTLR2 [O60603] with 784 residues is shown; res-
idues 1–588. The highly conserved segment of individual 
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Sequence alignment of LRR domains within the six families of TLRs Figure 5
Sequence alignment of LRR domains within the six families of TLRs. (1) hTLR1   [Q15399]; hTLR2 [O60603]; hTLR6 
[Q9Y2C9]; hTLR10 [Q9BXR5]; tTLR14 [Q5H726]. (2) hTLR3 [O15455];   jfTLR3 [Q76CT7]. (3) hTLR4 [O00204]; dTLR4 
[Q8SQH3]. (4) hTLR5 [O60602]. (5) mTLR11 [Q6R5P0];   mTLR12 [Q6QNU9]; mTLR13[Q6R5N8]: tTLR21 
[NP_001027751]; tTLR22 [Q5H723]; tTLR23 [AAW70378]; (6)   hTLR7 [Q9NYK1]; hTLR8 [Q9NR97]; hTLR9 [Q9NR96]. 
(7) jlTLRa [Q33E93]; cTLR15 [ABB71177].  The   complete amino acid sequences are shown for hTLR1 with 786 residues 
(res.), hTLR2 with 784 res,   hTLR6 with 796 res., hTLR10 with 811 res., tTLR14 with 871 res., hTLR3 with 904 res., jfTLR3   
with 961 res., hTLR4 with 839 res., dTLR4 with 636 res., hTLR5 with 858 res., hTLR7 with 1049   res., hTLR8 with 1041 res., 
hTLR9 with 1032 res., mTLR11 with 926 res., mTLR12 with 906 res.,   mTLR13 with 991 res., tTLR21 with 965 res., tTLR22 
with 950 res., tTLR23 with 941res., jlTLRa   with 813res., and cTLR15 with 868 res.,  Cysteine is highlighted in magenta. Its 
boldface   indicates cysteines in LRRNT or LRRCT.  Residues of missense mutation are highlighted in blue   boldface. SIGNAL, 
signal peptide sequence; LRRNT, the cysteine clusters on the N-terminal side   of LRRs; LRRCT, the cysteine clusters on the 
C-terminal side of LRRs; TRANS, transmembrane   region; CYTOP, cytoplasmic region. Abbreviations: h, human; m, mouse; t, 
Takifugu rubripes; c,   chicken; d, dog; jf, Japanese flounder.  This panel shows hTLR1, hTLR2, jfTLR2 and TLR6 in the   TLR1 
family.
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Sequence alignment of LRR domains within the six families of TLRs Figure 6
Sequence alignment of LRR domains within the six families of TLRs. This panel    continued from Figure 5 shows hTLR10 and 
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Sequence alignment of LRR domains within the six families of TLRs Figure 7
Sequence alignment of LRR domains within the six families of TLRs.  This panel   continued in Figure 6 shows jfTLR3 (from 
LRR25 to CYTOP in the TLR3 family, hTLR4 and dTLR4 in the TLR4 family, hTLR5in the TLR5 family, and   mtLR11 (from SIG-
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Sequence alignment of LRR domains within the six families of TLRs Figure 8
Sequence alignment of LRR domains within the six families of TLRs. This panel   continued in Figure 7 shows mtTLR11 (from 
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Sequence alignment of LRR domains within the six families of TLRs Figure 9
Sequence alignment of LRR domains within the six families of TLRs. This panel   continued in Figure 8 shows tTLR22 and 
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Sequence alignment of LRR domains within the six families of TLRs Figure 10
Sequence alignment of LRR domains within the six families of TLRs.  This panel   continued in Figure 9 shows hTLR8 (from 
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One or two horseshoe domains of LRRs within TLRs
The TLR7 family (TLR7, TLR8, TLR9 and green puffer TLR)
have 27 LRRs and an additional 58–73 residues at the end
of LRR15 (Figures 9, and 10). Such a long region is also
observed in chicken TLR15 (Figure 10). Gibbard et al.,
[61] have considered two horseshoe domains of LRRs for
human TLR8. That is, LRR15 has been separated into an
LRR motif and 40 residues of undetermined structure.
Most of the known LRR structures have a cap, which
shields the hydrophobic core at the N- and C-terminii of
LRRs. We suggest that these 40 residues function as the
cap of the horseshoe structure, an intervening of hydro-
phobic core of LRR with a specific feature in TLRs. Thus, it
can be concluded that the LRRs in vertebrate TLRs form
one or two distinct horseshoe structures. Future structure
determinations should resolve the question.
The TLR1 family (TLR1, TLR2, TLR6, and TLR10) and the
TLR4 family share a common feature, the central part of
the LRR domain has a more irregular motif compared
with those at the N- and C-terminal parts. The LRR struc-
ture in the three families of TLR1, TLR4 and TLR7 might
show a structural flexibility at the central part. Alterna-
tively, the central part would play a key role in the func-
tion.
The LRR arc of TLRs is flat?
The LRR arc structures can be characterized by three
parameters- the inner radius of the arc (R), the mean rota-
tion angle about the central axis relating one β-strand to
the next ( ), and the tilt angle of the parallel β-strand
direction per turn (θt). A 3D circle fitting method to calcu-
late these geometrical parameters has been developed
[55]. The TLR3-LRR arc yields R = 26.5–26.6Å,   = 10.8–
10.9° and θt = 24.5–26.7°. The TLR3-LRR belongs to "typ-
ical" type. This R value is comparable to 22–36 Å for the
LRR arcs in Slit, FSHr, nogo receptor, decorin, and GPIbα
with "typical" LRRs [8,55,58]. In contrast, the θt value is
comparable to only those for Slit (-21°) and FSHr (-40°).
Also the θt value corresponds to 19–40° for ribonuclease
inhibitor and 15° for tropomodulin with "RI-like" LRRs.
That is, the TLR3-LRR arc is nearly flat. This indicates that
all other TLRs except for the TLR7 family and TLR15 might
adopt flat LRR arc.
Super-motif of LRRs in the TLR7 family
The present analysis reveals that the TLR7 family consist-
ing of TLR7, TLR8 and TLR9 and green puffer TLR contains
the super-motif consisting of STT. Such super motifs have
been observed in various LRR proteins [8,11]. One of
them is the SLRP family. The SLRP family forms five dis-
tinct subfamilies. Class I consists of biglycan, decorin, and
ϕ
ϕ
Super-repeat of LRRs in the TLR7 family of TLR7, TLR8 and TLR9 Figure 11
Super-repeat of LRRs in the TLR7 family of TLR7, TLR8 and TLR9. 
Forty-two superimposed, cross-dot matrices from human TLR7 
[Q9NYK1], mouse TLR7 [P58682], human TLR8 [Q9NR97], 
mouse TLR8 [P58682], human TLR9 [Q9NR96], mouse TLR9 
[Q9EQU3], and green puffer TLR [Q4S0D3] with the widow size 
of 21 residues and the stringency of 10 (upper) and with the 
widow size of 41 residues and the stringency of 20 (lower). The 
summed scores for the 21 ((7 × 6)/2) comparisons are repre-
sented by color. The order of higher scores is red > purple > blue 
> light blue. Residue 46–291, 46–291, 44–288, 44–283, 40–285, 
40–285, and 23–268 of human TLR7, mouse TLR7, human TLR8, 
mouse TLR8, human TLR9, and green puffer TLR, respectively, 
were used for the cross-dot matrices. The abscissa axis and the 
ordinate axis are residues number.BMC Genomics 2007, 8:124 http://www.biomedcentral.com/1471-2164/8/124
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asporin. Class II has three subclasses: lumican plus fibro-
modulin (IIA), PRELP plus keratocan (IIB), and osteoad-
herin (IIC). Class III consists of epiphycan, osteoglycin
and opticin. Class IV is more distantly related and consists
of chondroadherin and nyctalopin. Class V consists of
podocan. Their classes except for class IV contain the
super-motif. Super-motifs, S  and T, similar to those in
SLRP are also present in asporin-like proteins from
human and mouse, mouse fibromodulin-like proteins,
biglycan-like proteins from sea lamprey, oligodendrocyte-
myelin and glycoprotein (OMGP), the FLRT family from
human, mouse and Xenopus, and human ECM2 [8,62].
Furthermore, a preliminary analysis indicates that neph-
rocan, a novel member of the SLRP family [63], contains
an STT  motif. These observations suggest strongly that
"bacterial" and "typical" LRRs evolved from a common
precursor.
LRR variants in TLRs associated with diseases
A number of amino acid polymorphisms, which occur in
LRRs, have been reported in TLRs. Arbour et al., [64] first
identified two mutations of human TLR4, D299G and
T399I, which were associated with diminished airway
responsiveness to inhaled LPS. Since then, these two
mutations have been studied for their association with
various infectious and inflammatory diseases; results
regarding the effects of these mutations have been incon-
clusive [65-71]. D299G and T399I occur in LRR11 and
LRR15, respectively (Figure 7). D299G is near the convex
part, while T399I is located on the loop C-terminal to the
convex part. Very recently, Ohara et al., [72] reported that
one mutation, T135A, was associated with poorly-differ-
entiated gastric adenocarcinomas. T135A in LRR5 occur at
position 9 in the HCS part (Figure 7). Such a mutation has
been observed in many LRR proteins such as nyctalopin,
keratocan, GPIbα, GPIbβ and GPIX, which are associated
with human diseases [58]. Position 9 is generally occu-
pied by Asn or Cy and sometimes by Thr or Ser, whose
side chains form hydrogen bonds in the loop structure
[58]. The T135A mutation may disrupt the hydrogen
bond pattern in the loop.
Mouse TLR9 plays a role in defense against systemic
mouse cytomegalovirus infection. Mice with the muta-
tion, L499P, are highly susceptible to mouse cytomegalo-
virus infection and shows low levels of cytokine induction
and natural killer activation on viral infection [73]. L499P
is located at the short loop that connects the helical struc-
ture on the convex part (in LRR17) and the β-strand on
concave part (in LRR18) (Figure 10). That is, L499P in
Sequence alignment of super-repeat of LRRs within TLR7, TLR and TLR9 from human and mouse and TLR from green puffer Figure 12
Sequence alignment of super-repeat of LRRs within TLR7, TLR and TLR9 from human and mouse and TLR from green puffer. 
human TLR7 [Q9NYK1]; mouse TLR7 [P58682]; human TLR8 [Q9NR97]; mouse TLR8 [P58682]; human TLR9 [Q9NR96]; 
mouse TLR9 [Q9EQU3]; green puffer TLR [Q4S0D3]. Abbreviations: h, human; m, mouse; gp, green puffer.
hTLR7 LRR1-LRR3 HVIVDCTDKHLTEIPGGIPTN TTNLTLTINHIPDISPASFHRLDH LVEIDFRCNCV PIPLGSKNNMCIKRLQIKPRSFSGLTY
LRR4-LRR6 LKSLYLDGNQLLEIPQGLPPS LQLLSLEANNIFSIRKENLTELAN IEILYLGQNCY RNPCYVSYSIEKDAFLNLTK
LRR7-LRR9 LKVLSLKDNNVTAVPTVLPST LTELYLYNNMIAKIQEDDFNNLNQ LQILDLSGNCP RCYNAPFPCAPCKNNSPLQIPVNAFDALTE
mTLR7 LRR1-LRR3 HVIVDCTDKHLTEIPEGIPTN TTNLTLTINHIPSISPDSFRRLNH LEEIDLRCNCV PVLLGSKANVCTKRLQIRPGSFSGLSD
LRR4-LRR6 LKALYLDGNQLLEIPQDLPSS LHLLSLEANNIFSITKENLTELVN IETLYLGQNCY YRNPCNVSYSIEKDAFLVMRN
LRR7-LRR9 LKVLSLKDNNVTAVPTTLPPN LLELYLYNNIIKKIQENDFNNLNE LQVLDLSGNCP RCYNVPYPCTPCENNSPLQIHDNAFNSLTE
hTLR8 LRR1-LRR3 SVIAECSNRRLQEVPQTVGKY VTELDLSDNFITHITNESFQGLQN LTKINLNHNPN VQHQNGNPGIQSNGLNITDGAFLNLKN
LRR4-LRR6 LRELLLEDNQLPQIPSGLPES LTELSLIQNNIYNITKEGISRLIN LKNLYLAWNCY FNKVCEKTNIEDGVFETLTN
LRR7-LRR9 LELLSLSFNSLSHVPPKLPSS LRKLFLSNTQIKYISEEDFKGLIN LTLLDLSGNCP RCFNAPFPCVPCDGGASINIDRFAFQNLTQ
mTLR8 LRR1-LRR3 LVIAECNHRQLHEVPQTIGKY VTNIDLSDNAITHITKESFQKLQN LTKIDLNHNAK QQHPNENKNGMNITEGALLSLRN
LRR4-LRR6 LTVLLLEDNQLYTIPAGLPES LKELSLIQNNIFQVTKNNTFGLRN LERLYLGWNCY FKCNQTFKVEDGAFKNLIH
LRR7-LRR9 LKVLSLSFNNLFYVPPKLPSS LRKLFLSNAKIMNITQEDFKGLEN LTLLDLSGNCP RCYNAPFPCTPCKENSSIHIHPLAFQSLTQ
hTLR9 LRR2-LRR3 VTSLSLSSNRIHHLHDSDFAHLPS LRHLNLKWNCP PVGLSPMHFPCHMTIEPSTFLAVPT
LRR4-LRR6 LEELNLSYNNIMTVPA LPKS LISLSLSHTNILMLDSASLAGLHA LRFLFMDGNCY YKNPCRQALEVAPGALLGLGN
LRR7-LRR9 LTHLSLKYNNLTVVPRNLPSS LEYLLLSYNRIVKLAPEDLANLTA LRVLDVGGNCR RC DHAPNPCMECPRHFPQLHPDTFSHLSR
mTLR9 LRR2-LRR3 ITRLSLISNRIHHLHNSDFVHLSN LRQLNLKWNCP PTGLSPLHFSCHMTIEPRTFLAMRT
LRR4-LRR6 LEELNLSYNGITTVPR LPSS LVNLSLSHTNILVLDANSLAGLYS LRVLFMDGNCY YKNPCTGAVKVTPGALLGLSN
LRR7-LRR9 LTHLSLKYNNLTKVPRQLPPS LEYLLVSYNLIVKLGPEDLANLTS LRVLDVGGNCR RC DHAPNPCIECGQKSLHLHPETFHHLSH
gpTLR LRR2-LRR3 VVNVDCTERSLTDVPHGIPRD VSNLTLTINHIPNFNSTSFQGLDN LREVDMRCNCV PVKIGPKDHICTKSVTIEENTFNSLKN
LRR4-LRR6 LQSLYLDGNQLYSIPKGLPSS LILLSLEVNHIYYISKANLSEIRN VEILYLGQNCY YRNPCNFSYGIEDGAFLELYN
LRR7-LRR9 LKLLSLKSNNLSFIPHHLPSS LKELYLYNNNFQSVSAEDFKNLTN LEILDISGNCP RCYNVPFPCNPCPNNAPLKISKEAFKTLTK
Consensus LxxLxLxxNxLxxIPxxLPxx LxxLxLxxNxLxxLxxxxFxxLxx LxxLxLxxNCx xxxxxxxxxxxxxxxxxxxIxxxxFxxLxx
LRR Type S  T  T BMC Genomics 2007, 8:124 http://www.biomedcentral.com/1471-2164/8/124
Page 17 of 20
(page number not for citation purposes)
LRR18 occur at position 1 in the HCS part. The side chain
of L499 is completely buried in the LRR arc. Such a muta-
tion is also observed in trk-A and nyctalopin, which are
associated with human diseases [58]. The mutation of
D543A in human TLR8 abolishes the binding of CpG
DNA [61]. D543A in LRR19 occur at position 1 in the VS
part. Thus, D543A is located at the edge between the con-
vex and the concave parts of the LRR arc. The Cys-to-Ala
mutations in the VS part of LRR9 (C257A, C260A, C267A,
and C270A) completely abolish signaling by TLR8 [61].
Hidaka et al., [74] detected one mutation, F303, in human
TLR3 in one of three patients with influenza-associated
encephalopathy. This was a loss-of-function mutation.
F303S in LRR12 is located at position 4 in the HCS part.
The side chain of F303 is completely buried in the LRR arc.
Two mutations, H539E and N541A, resulted in the loss of
TLR3 activation and ligand binding functions [75]. These
two mutations occur in LRR21.
Conclusion
The new method of alignment proposed here rationalizes
the difference in the repeat numbers of LRRs and their
"phasing" within TLRs in different databases and for vari-
ous species and isoforms. Moreover, the new method
indicates that each of the six TLR families is characterized
by their LRR motifs, their repeat numbers, and the motifs
of cysteine clusters. The repeat number of LRRs is larger
than those previously reported in databases. The central
part in the LRR domains within the TLR1 family and TLR4
has more irregular motifs compared with the N- and C-ter-
minal parts. Moreover, the TLR7 family contains a region
with 58–73 residues in the central part of the LRR domain.
The central parts are inferred to play a key role in the struc-
ture and/or function of their TLRs. The LRRs in TLRs form
one or two horseshoe domains. The LRR arc of TLRs is also
predicted to be nearly flat. Furthermore, the LRR super-
motif in the TLR7 family suggests strongly that "bacterial"
and "typical" LRRs evolved from a common precursor.
The present analysis should stimulate and facilitate vari-
ous experimental studies to understand the molecular
mechanism of TLR-ligand interactions.
Methods
Known structures of LRR proteins
The structures of twenty-two different LRR proteins have
been determined. They are ribonuclease inhibitor (RI)
[2NBH, I1DJ, LA4Y, 1Z7X], GTPase-activating protein
(RanGAP) [1YRG, 1K5D, 1K5G], tropomodulin (Tmod)
[1IO0, 1PGV], S-phase kinase-associated protein 2 (Skp2)
[1FQV], YopM [1G9U], four internalins, Inl-B [1D0B],
Inl-H [1H6U], Inl-A [106T, 106V, 106S] and Inl-C
[1XEU], spliceosomal U2A' protein [1A9N], mRNA export
factor (TAP) [1FT8, 1F01], rab geranylgeranyltransferase
α-subunit (RabGGTα) [1DCE, 1LTX], Chlamydomonas
outer arm dynein light chain 1 (DLC-1) [1DS9], polyga-
lacturonase-inhibiting protein (PGIP) [10GQ], nogo
receptor/nogo-66 receptor (NgR) [10ZN, 1P9A], glyco-
protein Ibα (GPIbα) [1M0Z, 1GWB, 1QYY, 1M10, 1SQ0,
1P8V, 100K, 1P9A, 1U0N], decorin [1XCD, 1XKU, 1XEC],
biglycan [2FT3], Slit [1W8A], CD14 [1WWL], follicle-
stimulating hormone receptor (FSHr) [1XWD], TLR3
[1ZIW, 2A0Z], and human lingo-1 [2ID5].
Amino acid sequences
The LRRs alignments within the TLR family were made for
TLR1 from four species (human [Q15399, Q5FWG5,
Q6FI64, Q32MK3], mouse [Q9EPQ1], pig [Q4LDR7,
Q59HI9], Takifugu rubripes [Q5H727]); TLR2 from 17
species (human [O60603], mouse [Q9QUN7, Q8K3D9,
Q811T5], pig [Q59HI8, Q5DX20, Q76L24], chicken
[Q9DD78 (TLR2.1), Q9DGB6 (TLR2.2)], bovine
[Q95LA9], rat [Q6YGU2], dog [Q689D1], rabbit
[AAM50059], goat [ABI31733], horse [AAR08196], ham-
ster [Q9R1F8], Cynomolgus monkey [Q95M53], domes-
tic water buffalo [Q2PZH4], Nilgai [Q2V897], Takifugu
rubripes [Q5H725], zebrafish [Q6TS42], Japanese floun-
der [Q76CT8]); TLR3 from 9 species (human [O15455,
Q4VAL2, Q504W0], mouse [Q99MB1, Q3TM31,
Q499F3], bovine [Q5TJ58, Q5TJ59], rat [Q7TNI8], buf-
falo [Q1G1A3], Rhesus macaque [Q3BBY1], Takifugu
rubripes [Q5H721], zebrafish [Q6IWL5, Q32PW5], Japa-
nese flounder [Q76CT7, Q76CT9]; TLR4 from 17 species
(human [O00206, Q5VZI7, Q5VZI8, Q5VZI9], mouse
[Q9QUK6, Q5RGT4, Q8K2T5], pig [Q68Y56, Q2TNK4,
Q5F4K7, Q401C7], bovine [Q9GL65, Q6WCD5,
Q8SQ55], rat [Q9QX05], hamster [Q9WV82], cat
[P58727], lowland gorilla [Q8SPE8], horse [Q9MYW3],
Pygmy chimpanzee [Q9TTN0], olive baboon [Q9TSP2],
orangutan [Q8SPE9], Nilgai [Q2V898], American bison
[Q3ZD70], dog [Q8SQH3], rabbit [AAM50060];
zebrafish [Q6NV08, Q6TS41(TLR4b)]; TLR5 from 8 spe-
cies (human [O60602], pig [Q59HI7], mouse [Q9JLF7],
bovine [Q2LDA0], chicken [Q4ZJ82], Japanese house
mouse [Q1ZZX0], Takifugu rubripes [Q5H720,
Q5H716(TLRS5)], rainbow trout [Q7ZT81]); TLR6 from
5 species (human [Q9Y2C9], mouse [Q9EPW9,
Q7TPC5], rat [Q6P690], pig [Q59HI6, Q76L23], bovine
[Q704V6, Q706D2]; TLR7 from 4 species (human
[Q9NYK1], mouse [P58681, Q548J0], dog [Q2L4T3],
Takifugu rubripes [Q5H719]); TLR8 from 4 species
((human [Q9NR97, Q495P4, Q495P6, Q495P7], mouse
[P58682], pig [Q865R7], Takifugu rubripes [Q5H718]);
TLR9 from 12 species (human [Q9NR96[, mouse
[Q9EQU3], pig [Q5I2M3, Q865R8], bovine [Q5I2M5,
Q866B2], dog [Q5I2M8], cat [Q5I2M7], Japanese floun-
der [Q2ABQ3], horse [Q2EEY0], sheep Q5I2M4], Ma's
night monkey [Q56R09], Gilthead sea bream [Q3L273,
Q3L274], Takifugu rubripes [Q5H717]]; TLR10 from two
species (human [Q9BXR5, Q5FWG4, Q32MI7, Q32MI8],BMC Genomics 2007, 8:124 http://www.biomedcentral.com/1471-2164/8/124
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pig [Q4LDR6, Q59HI5]); TLR11 from mouse [Q6R5P0,
Q32ME8]; TLR12 from mouse [Q6QNU9]; TLR13 from
mouse [Q6R5N8]; TLR14 from Takifugu rubripes
[Q5H726] and zebrafish [XP_687315]; TLR15 from
chicken [ABB71177], TLR21 from Takifugu rubripes
[NP_001027751], TLR22 from Takifugu rubripes
[Q5H723], TLR23 from Takifugu rubripes [AAW70378],
and TLR from rainbow trout [Q6KCC7, Q4LBC9], Atlan-
tic salmon [Q2A132], goldfish [Q801F9]), Japanese lam-
prey [Q33E92, Q33E93] and green puffer (Fragment)
[Q4S0D3]).
The prediction of secondary structure, signal peptide and 
membrane-spanning region in protein
The protein secondary structure prediction by SSpro4.0
[13,76,77]and Proteus [12,78] were utilized for the deter-
mination and assignments of LRRs within TLRs. Signal
peptide prediction was performed by SignalP 3.0 [79,80].
The prediction of membrane-spanning regions in proteins
was performed by the TMHMM Program [81,82]. The
PFAM program [83] was used to detect LRRs in TLRs.
Multiple sequence alignment, sequence similarity search 
and dot plot analysis
Multiple sequence alignments and sequence similarity
searches were performed at Bioinformatic Center, Insitute
for Chemical Research, Kyoto University [84]. Dot-matrix
comparisons were performed using the Blosum90 scoring
matrix. The program was made in house. Window sizes
and stringencies are indicated in figure legends.
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